Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Irritable Bowel Syndrome

  Free Subscription

Articles published in J Gastroenterol Hepatol

Retrieve available abstracts of 72 articles:
HTML format

Single Articles

    August 2021
  1. WANG XY, Wang H, Guan YY, Cai RL, et al
    Acupuncture for functional gastrointestinal disorders: a systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2021 Aug 3. doi: 10.1111/jgh.15645.
    PubMed     Abstract available

    June 2021
  2. SCHINDLER V, Giezendanner S, Van Oudenhove L, Murray FR, et al
    Better response to low FODMAP diet in DGBI patients with pronounced hydrogen response to a nutrient challenge test.
    J Gastroenterol Hepatol. 2021 Jun 9. doi: 10.1111/jgh.15573.
    PubMed     Abstract available

    April 2021
  3. ZHANG W, Chen X, Wong KC
    Noninvasive early diagnosis of intestinal diseases based on artificial intelligence in genomics and microbiome.
    J Gastroenterol Hepatol. 2021;36:823-831.
    PubMed     Abstract available

    February 2021
  4. QUEK SXZ, Loo EXL, Demutska A, Chua CE, et al
    The Impact of the Coronavirus Disease 2019 (COVID-19) pandemic on Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2021 Feb 21. doi: 10.1111/jgh.15466.
    PubMed     Abstract available

  5. BOUCHOUCHA M, Deutsch D, Uong P, Mary F, et al
    Characteristics of patients with overlap functional gastrointestinal disorders.
    J Gastroenterol Hepatol. 2021 Feb 8. doi: 10.1111/jgh.15438.
    PubMed     Abstract available

    January 2021
  6. GOYAL O, Batta S, Nohria S, Kishore H, et al
    Low FODMAP diet in patients with diarrhoea predominant irritable bowel syndrome: a prospective, randomised trial.
    J Gastroenterol Hepatol. 2021 Jan 19. doi: 10.1111/jgh.15410.
    PubMed     Abstract available

    December 2020
  7. CHEN N, Liu G, Guo M, Li Y, et al
    Calcarine as a bridge between brain function and structure in Irritable Bowel Syndrome: a multiplex network analysis.
    J Gastroenterol Hepatol. 2020 Dec 22. doi: 10.1111/jgh.15382.
    PubMed     Abstract available

    November 2020
  8. OSHIMA T, Siah KTH, Yoshimoto T, Miura K, et al
    Impacts of the COVID2019 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey.
    J Gastroenterol Hepatol. 2020 Nov 16. doi: 10.1111/jgh.15346.
    PubMed     Abstract available

    October 2020
  9. TOMITA T, Kazumori K, Baba K, Zhao X, et al
    Impact of Chronic Constipation on Health-Related Quality of Life and Work Productivity in Japan.
    J Gastroenterol Hepatol. 2020 Oct 13. doi: 10.1111/jgh.15295.
    PubMed     Abstract available

    August 2020
  10. MIURA K, Oshima T, Ito C, Horikawa T, et al
    Vitamin D receptor is overexpressed in the duodenum of patients with irritable bowel syndrome.
    J Gastroenterol Hepatol. 2020 Aug 24. doi: 10.1111/jgh.15225.
    PubMed     Abstract available

    May 2020
  11. BRUNKWALL L, Ericson U, Nilsson PM, Orho-Melander M, et al
    Self-reported bowel symptoms are associated with differences in overall gut microbiota composition and enrichment of Blautia in a population-based cohort.
    J Gastroenterol Hepatol. 2020 May 19. doi: 10.1111/jgh.15104.
    PubMed     Abstract available

    March 2020
    Marshall and Warren Lecture 2019: A paradigm shift in pathophysiological basis of irritable bowel syndrome and its implication on treatment.
    J Gastroenterol Hepatol. 2020 Mar 11. doi: 10.1111/jgh.15032.
    PubMed     Abstract available

    January 2020
  13. WONG MYW, Hebbard G, Gibson PR, Burgell RE, et al
    J Gastroenterol Hepatol. 2020 Jan 3. doi: 10.1111/jgh.14970.
    PubMed     Abstract available

    November 2019
  14. GHOSHAL UC, Nehra A, Mathur A, Rai S, et al
    A meta-analysis on small intestinal bacterial overgrowth in patients with different sub-types of irritable bowel syndrome.
    J Gastroenterol Hepatol. 2019 Nov 21. doi: 10.1111/jgh.14938.
    PubMed     Abstract available

  15. CHAN Y, Cheong PK, Fang FF, Cheung CKY, et al
    A symptom severity questionnaire for patients suffering from functional gastrointestinal disorder: FGI-checklist.
    J Gastroenterol Hepatol. 2019 Nov 16. doi: 10.1111/jgh.14937.
    PubMed     Abstract available

    October 2019
  16. TAN N, Gwee KA, Tack J, Zhang M, et al
    Herbal medicine in the treatment of functional gastrointestinal disorders: A systematic review with meta-analysis.
    J Gastroenterol Hepatol. 2019 Oct 31. doi: 10.1111/jgh.14905.
    PubMed     Abstract available

  17. YANG M, Zhang L, Hong G, Li Y, et al
    Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant IBS.
    J Gastroenterol Hepatol. 2019 Oct 31. doi: 10.1111/jgh.14910.
    PubMed     Abstract available

    August 2019
  18. BASNAYAKE C, Kamm MA, Salzberg MR, Wilson-O'Brien A, et al
    Delivery of Care for Functional Gastrointestinal Disorders: A Systematic Review.
    J Gastroenterol Hepatol. 2019 Aug 14. doi: 10.1111/jgh.14830.
    PubMed     Abstract available

    April 2019
  19. STASI C, Caserta A, Nisita C, Cortopassi S, et al
    The complex interplay between gastrointestinal and psychiatric symptoms in irritable bowel syndrome: A longitudinal assessment.
    J Gastroenterol Hepatol. 2019;34:713-719.
    PubMed     Abstract available

    March 2019
  20. MAK DPA, Chung CHV, Suet Ying Y, Tse YK, et al
    Electroacupuncture is Not Effective For Comorbid Generalized Anxiety Disorder & Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2019 Mar 19. doi: 10.1111/jgh.14667.
    PubMed     Abstract available

  21. WONG MW, Bair MJ, Chang WC, Hsu CS, et al
    Clinical and psychological characteristics in GERD patients overlapping with laryngopharyngeal reflux symptoms.
    J Gastroenterol Hepatol. 2019 Mar 8. doi: 10.1111/jgh.14651.
    PubMed     Abstract available

  22. HALMOS EP, Gibson PR
    Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome.
    J Gastroenterol Hepatol. 2019 Mar 8. doi: 10.1111/jgh.14650.
    PubMed     Abstract available

    November 2018
  23. SCHINDLER V, Giezendanner S, Butikofer S, Murray F, et al
    Differentiation of functional gastrointestinal disorders from healthy volunteers by lactulose hydrogen breath test and test meal.
    J Gastroenterol Hepatol. 2018 Nov 22. doi: 10.1111/jgh.14551.
    PubMed     Abstract available

  24. IVASHKIN V, Sheptulin A, Shifrin O, Poluektova E, et al
    Clinical validation of the '7x7' questionnaire for patients with functional gastrointestinal disorders.
    J Gastroenterol Hepatol. 2018 Nov 21. doi: 10.1111/jgh.14546.
    PubMed     Abstract available

  25. ZHANG J, Song L, Wang Y, Liu C, et al
    Reduction in butyrate-producing Lachnospiraceae contributes to stress-induced visceral hypersensitivity in rats.
    J Gastroenterol Hepatol. 2018 Nov 6. doi: 10.1111/jgh.14536.
    PubMed     Abstract available

    August 2018
  26. NG QX, Soh AYS, Loke W, Venkatanarayanan N, et al
    Systematic Review with Meta-analysis: The Association between Post-traumatic Stress Disorder (PTSD) and Irritable Bowel Syndrome (IBS).
    J Gastroenterol Hepatol. 2018 Aug 25. doi: 10.1111/jgh.14446.
    PubMed     Abstract available

    July 2018
  27. NOZU T, Miyagishi S, Kumei S, Nozu R, et al
    Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats.
    J Gastroenterol Hepatol. 2018 Jul 2. doi: 10.1111/jgh.14367.
    PubMed     Abstract available

    May 2018
  28. CHEN YJ, Wu H, Wu SD, Lu N, et al
    Parasutterella, in associated with Irritable Bowel Syndrome and intestinal chronic inflammation.
    J Gastroenterol Hepatol. 2018 May 9. doi: 10.1111/jgh.14281.
    PubMed     Abstract available

    April 2018
  29. GWEE KA, Lee WW, Ling KL, Ooi CJ, et al
    Consensus and contentious statements on the use of probiotics in clinical practice: a South East Asian Gastro-neuro Motility Association Working Team Report.
    J Gastroenterol Hepatol. 2018 Apr 26. doi: 10.1111/jgh.14268.
    PubMed     Abstract available

    January 2018
  30. YANG Y, Fang J, Guo X, Dai N, et al
    Linaclotide in Irritable Bowel Syndrome with Constipation: A Phase 3 Randomized Trial in China and Other Regions.
    J Gastroenterol Hepatol. 2018 Jan 10. doi: 10.1111/jgh.14086.
    PubMed     Abstract available

    November 2017
  31. LI G, Yang M, Jin Y, Li Y, et al
    Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
    J Gastroenterol Hepatol. 2017 Nov 30. doi: 10.1111/jgh.14059.
    PubMed     Abstract available

  32. ZAHEDI MJ, Behrouz V, Azimi M
    Low FODMAPs diet vs. general dietary advice improves clinical response in patients with diarrhea-predominant irritable bowel syndrome: a randomized controlled trial.
    J Gastroenterol Hepatol. 2017 Nov 20. doi: 10.1111/jgh.14051.
    PubMed     Abstract available

  33. TALLEY NJ, Holtmann G, Nguyen QN, Gibson P, et al
    Undiagnosed pancreatic exocrine insufficiency and chronic pancreatitis in functional GI disorder patients with diarrhea or abdominal pain.
    J Gastroenterol Hepatol. 2017;32:1813-1817.
    PubMed     Abstract available

    September 2017
  34. GWEE KA, Ghoshal UC, Chen M
    Irritable bowel syndrome in Asia: pathogenesis, natural history, epidemiology and management.
    J Gastroenterol Hepatol. 2017 Sep 13. doi: 10.1111/jgh.13987.
    PubMed     Abstract available

    August 2017
  35. KHAYYATZADEH SS, Kazemi-Bajestani SMR, Mirmousavi SJ, Heshmati M, et al
    Dietary behaviors in relation to prevalence of irritable bowel syndrome in adolescent girls.
    J Gastroenterol Hepatol. 2017 Aug 2. doi: 10.1111/jgh.13908.
    PubMed     Abstract available

  36. MALAGELADA C, Nieto A, Mendez S, Accarino A, et al
    Effect of prucalopride on intestinal gas tolerance in patients with functional bowel disorders and constipation.
    J Gastroenterol Hepatol. 2017;32:1457-1462.
    PubMed     Abstract available

  37. XIONG L, Gong X, Siah KT, Pratap N, et al
    Rome foundation Asian working team report: Real world treatment experience of Asian patients with functional bowel disorders.
    J Gastroenterol Hepatol. 2017;32:1450-1456.
    PubMed     Abstract available

    July 2017
  38. HEWAWASAM SP, Iacovou M, Muir JG, Gibson PR, et al
    Dietary Practices and Fodmaps in South Asia: Applicability of the Low Fodmap Diet to Patients with Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2017 Jul 12. doi: 10.1111/jgh.13885.
    PubMed     Abstract available

    June 2017
  39. JIN Y, Ren X, Li G, Li Y, et al
    Rifaximin exerts beneficial effects in PI-IBS mouse model beyond gut microbiota.
    J Gastroenterol Hepatol. 2017 Jun 1. doi: 10.1111/jgh.13841.
    PubMed     Abstract available

    May 2017
  40. FYSEKIDIS M, Bouchoucha M, Mary F, Airinei G, et al
    Change of appetite in patients with Functional digestive Disorder. Association with psychological disorders: a cross-sectional study.
    J Gastroenterol Hepatol. 2017 May 27. doi: 10.1111/jgh.13836.
    PubMed     Abstract available

  41. QUACH DT, Hiyama T, Nguyen TA, Ly HQ, et al
    The Asia-Pacific Colorectal Screening Score Is Useful To Stratify Risk for Colorectal Advanced Neoplasms in Vietnamese Patients with Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2017 May 11. doi: 10.1111/jgh.13821.
    PubMed     Abstract available

    April 2017
  42. NOZU T, Miyagishi S, Kumei S, Nozu R, et al
    A glucagon-like peptide-1 analog, liraglutide improves visceral sensation and gut permeability in rats.
    J Gastroenterol Hepatol. 2017 Apr 25. doi: 10.1111/jgh.13808.
    PubMed     Abstract available

    March 2017
    Use of the low-FODMAP diet in inflammatory bowel disease.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:40-42.
    PubMed     Abstract available

  44. ANKERSEN DV, Carlsen K, Marker D, Munkholm P, et al
    Using eHealth strategies in delivering dietary and other therapies in patients with irritable bowel syndrome and inflammatory bowel disease.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:27-31.
    PubMed     Abstract available

    Adapting the low FODMAP diet to special populations: infants and children.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:43-45.
    PubMed     Abstract available

    History of the low FODMAP diet.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:5-7.
    PubMed     Abstract available

  47. WILSON B, Whelan K
    Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:64-68.
    PubMed     Abstract available

  48. TAN VP
    The low-FODMAP diet in the management of functional dyspepsia in East and Southeast Asia.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:46-52.
    PubMed     Abstract available

    How to institute the low-FODMAP diet.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:8-10.
    PubMed     Abstract available

    The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first-line therapy?
    J Gastroenterol Hepatol. 2017;32 Suppl 1:32-35.
    PubMed     Abstract available

  51. GIBSON PR, Skodje GI, Lundin KE
    Non-coeliac gluten sensitivity.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:86-89.
    PubMed     Abstract available

    When the low FODMAP diet does not work.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:69-72.
    PubMed     Abstract available

  53. VARNEY J, Barrett J, Scarlata K, Catsos P, et al
    FODMAPs: food composition, defining cutoff values and international application.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:53-61.
    PubMed     Abstract available

  54. TUCK C, Barrett J
    Re-challenging FODMAPs: the low FODMAP diet phase two.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:11-15.
    PubMed     Abstract available

  55. O'KEEFFE M, Lomer MC
    Who should deliver the low FODMAP diet and what educational methods are optimal: a review.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:23-26.
    PubMed     Abstract available

    Bioactive food chemicals and gastrointestinal symptoms: a focus of salicylates.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:73-77.
    PubMed     Abstract available

  57. MEANCE S, Giordano J, Chuang E, Schneider H, et al
    Food regulations: low FODMAP labeling and communication goals.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:62-63.
    PubMed     Abstract available

    Nutritional, microbiological and psychosocial implications of the low FODMAP diet.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:16-19.
    PubMed     Abstract available

    February 2017
  59. SAHOO S, Padhy SK
    Cross-cultural and Psychological issues in Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2017 Feb 27. doi: 10.1111/jgh.13773.
    PubMed     Abstract available

  60. CHOI YJ, Kim N, Yoon H, Shin CM, et al
    Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
    J Gastroenterol Hepatol. 2017 Feb 4. doi: 10.1111/jgh.13756.
    PubMed     Abstract available

  61. HARVIE R, Walmsley R, Schultz M
    "We are what our bacteria eat": The role of bacteria in personalizing nutrition therapy in gastrointestinal conditions.
    J Gastroenterol Hepatol. 2017;32:352-357.
    PubMed     Abstract available

    November 2016
  62. BAI T, Xia J, Jiang Y, Cao H, et al
    Comparison of the Rome IV and Rome III criteria for IBS diagnosis: a cross-sectional survey.
    J Gastroenterol Hepatol. 2016 Nov 10. doi: 10.1111/jgh.13642.
    PubMed     Abstract available

    October 2016
  63. LOKTIONOV A, Chhaya V, Bandaletova T, Poullis A, et al
    Inflammatory bowel disease detection and monitoring by measuring biomarkers in non-invasively collected colorectal mucus.
    J Gastroenterol Hepatol. 2016 Oct 27. doi: 10.1111/jgh.13627.
    PubMed     Abstract available

    September 2016
  64. THORSVIK S, Damas JK, van Beelen Granlund A, Flo TH, et al
    Fecal Neutrophil Gelatinase Associated Lipocalin (NGAL) as a biomarker for Inflammatory Bowel Disease.
    J Gastroenterol Hepatol. 2016 Sep 18. doi: 10.1111/jgh.13598.
    PubMed     Abstract available

    August 2016
  65. QI Q, Chen F, Zhang W, Wang P, et al
    Colonic N-methyl-D-aspartate receptor contributes to visceral hypersensitivity in irritable bowel syndrome.
    J Gastroenterol Hepatol. 2016 Aug 30. doi: 10.1111/jgh.13588.
    PubMed     Abstract available

    June 2016
  66. ZHUANG X, Xiong L, Li L, Li M, et al
    Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2016 Jun 14. doi: 10.1111/jgh.13471.
    PubMed     Abstract available

  67. GHOSHAL UC, Singh R
    Frequency and risk factors of functional gastro-intestinal disorders in a rural Indian population.
    J Gastroenterol Hepatol. 2016 Jun 5. doi: 10.1111/jgh.13465.
    PubMed     Abstract available

    April 2016
  68. GONZALEZ-CASTRO AM, Martinez C, Salvo-Romero E, Fortea M, et al
    Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2016 Apr 18. doi: 10.1111/jgh.13417.
    PubMed     Abstract available

    February 2016
  69. YAO X, Yang YS, Cui LH, Sun G, et al
    The overlap of Upper Functional Gastrointestinal disorders with Irritable Bowel Syndrome in Chinese Outpatients: a multi-center study.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13317.
    PubMed     Abstract available

  70. LOBO B, Serra J, D'Amato M, Rovati L, et al
    Effect of selective CCK1 receptor antagonism on accommodation and tolerance of intestinal gas in functional gut disorders.
    J Gastroenterol Hepatol. 2016;31:288-93.
    PubMed     Abstract available

    January 2016
  71. HSU LT, Hung KY, Wu HW, Liu WW, et al
    Gut-derived cholecystokinin contributes to visceral hypersensitivity via nerve growth factor-dependent neurite outgrowth.
    J Gastroenterol Hepatol. 2016 Jan 15. doi: 10.1111/jgh.13296.
    PubMed     Abstract available

    December 2015
  72. TADA Y, Ishihara S, Kawashima K, Fukuba N, et al
    Down-regulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low grade inflammation in ulcerative colitis.
    J Gastroenterol Hepatol. 2015 Dec 16. doi: 10.1111/jgh.13268.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.